Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Docusign, Inc. (NASDAQ: DOCU), a software company focused on digital agreements, eSignature, and Intelligent Agreement Management (IAM). Through these filings, investors can review the company’s official disclosures on financial performance, risk factors, governance, and key business developments.
Annual reports on Form 10-K typically include detailed discussions of DocuSign’s business, including its IAM platform, eSignature and contract lifecycle management offerings, customer base, and the risks and opportunities associated with its operations. Quarterly reports on Form 10-Q provide interim financial statements, management’s discussion and analysis, and updates on metrics such as revenue, subscription trends, billings, and cash flows.
Current reports on Form 8-K disclose material events, such as quarterly financial results and certain corporate governance changes. For example, DocuSign has used Form 8-K to report financial results for specific quarters and to announce board appointments and leadership roles. These filings help investors track significant developments between regular reporting periods.
Other filings, such as proxy statements and any Form 4 insider transaction reports, can offer additional insight into executive and director compensation, equity awards, and share ownership, as well as governance practices. Together, these documents form the regulatory record of DOCU as a Nasdaq-listed issuer.
On Stock Titan, SEC filings for DOCU are updated from the EDGAR system, and AI-powered summaries can assist readers by highlighting key points from lengthy documents like 10-Ks and 10-Qs. This can help users quickly understand DocuSign’s reported results, non-GAAP metrics, and material events without reading every page of each filing.
DocuSign common stockholder Blake J. Grayson has filed a Form 144 notice to sell 6,500 shares of DocuSign common stock, with an aggregate market value of $455,000. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/09/2026. The shares to be sold are common stock originally acquired as restricted stock from the issuer on 06/10/2024, in the same 6,500-share amount.
The notice also reports that during the past three months, Blake J. Grayson sold an additional 9,515 DocuSign common shares on 12/17/2025 for gross proceeds of $650,214.18. The filing states that DocuSign had 200,272,740 common shares outstanding. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about DocuSign’s current or prospective operations.
DocuSign, Inc. Chief Revenue Officer Paula Hansen reported multiple open-market sales of company common stock. On January 2, 2026, she sold a total of 6,000 shares of DocuSign common stock in four separate transactions, at reported prices of $65.43, $66.94, $67.78, and $68.62 per share.
The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted by Hansen, which is designed to allow insiders to sell shares according to a preset schedule. Following the reported sales, Hansen directly beneficially owned 68,970 shares of DocuSign common stock.
Docusign, Inc. reported that its Chief Legal Officer, James P. Shaughnessy, sold common stock in multiple transactions on 01/02/2026. He sold a total of 12,000 shares of Docusign common stock in four separate sales, at prices generally between $64.97 and $68.68, as reflected by the detailed price ranges in the footnotes. These sales were executed pursuant to a Rule 10b5-1 trading plan previously adopted by Shaughnessy. Following the reported transactions, he beneficially owned 54,550 shares of Docusign common stock directly.
DocuSign, Inc. director reported an insider transaction involving company common stock. On 12/10/2025, the reporting person made a transaction coded "G" (a gift) of 15,000 shares of common stock at a stated price of $0, held indirectly through a trust.
After this transaction, the reporting person beneficially owned 120,253 shares of DocuSign common stock indirectly through a trust, in addition to 7,512 shares held directly, 65,558 shares held indirectly by children's trusts, 6,458 shares held indirectly by a spouse, and 3 shares held indirectly through a family partnership.
DocuSign, Inc. Chief Financial Officer, identified as an officer of the company, reported multiple equity transactions in December 2025. On 12/15/2025, the CFO acquired 37,453 shares of common stock at $0 through the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs), and 15,385 shares were withheld to cover tax obligations. Following these transactions, the CFO directly held 127,728 shares of common stock.
On 12/17/2025, the CFO sold 3,525 shares at an average price within a range of $67.31 to $68.29, and 5,990 shares at prices ranging from $68.33 to $69.05, under a pre-established Rule 10b5-1 trading plan. The filing also details ongoing RSU and PSU awards that vest over several years or based on DocuSign’s FY25 subscription revenue and free cash flow performance.
DocuSign's chief legal officer reported multiple stock-based compensation events on December 15, 2025. Several batches of restricted stock units (RSUs) and performance stock units (PSUs) converted into common stock at an exercise price of $0, adding 20,968 shares of common stock.
To cover taxes on these vestings, 9,860 shares were withheld by the company, reducing the net increase in directly held stock. After the reported transactions, the officer directly owned 66,550 shares of DocuSign common stock. The filing also details remaining RSU and PSU awards that continue to vest over time based on service and performance conditions tied to subscription revenue and free cash flow for specified performance periods.
DocuSign, Inc.’s Chief Revenue Officer reported equity award activity involving company stock. On 12/15/2025, the executive acquired 32,515 shares of DocuSign common stock at $0 following the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). To cover tax obligations triggered by this vesting, 16,513 shares were withheld by the company, also at $0 per share. After these transactions, the officer directly beneficially owned 74,970 shares of common stock. The filing also shows continuing holdings of RSUs and PSUs that may convert into additional shares over time, subject to time-based vesting, performance targets tied to subscription revenue and free cash flow for the FY25 performance period, and continued service conditions.
DocuSign, Inc. reported insider stock activity by its President and General Manager, Growth. On December 15, 2025, the executive sold 1,683 shares of common stock at $70.87 per share under a Rule 10b5-1 trading plan. That same day, vested equity awards were exercised, adding 31,538 shares, and the company withheld 16,019 shares at no price to cover tax obligations from vesting restricted and performance stock units.
On December 17, 2025, the executive completed additional open-market sales of 5,253 shares at an average price of $67.88 and 8,565 shares at an average price of $68.61, with exact prices ranging from $67.31 to $69.05. Following these transactions, the executive directly held 70,197 shares of DocuSign common stock, along with multiple tranches of restricted stock units and performance stock units that may convert into shares over time based on service and performance conditions.
DocuSign, Inc. President and CEO, who also serves as a director, reported equity award activity dated 12/15/2025. The filing shows the exercise and settlement of restricted stock units into 65,561 shares of common stock, with 33,296 shares withheld to cover tax obligations, leaving 168,511 shares of common stock held directly after the transactions.
Multiple grants of restricted stock units and performance stock units remain outstanding, each convertible into common stock at an exercise price of $0. These awards vest over multi‑year schedules, generally in quarterly installments, conditioned on continued service and, for performance stock units, on achieving subscription revenue and free cash flow targets for the FY24 and FY25 performance periods, with potential vesting capped at 200% of target.
DocuSign, Inc. reported that one of its officers, listed as President General Mgr, Growth, sold 983 shares of common stock on 12/11/2025.
The sale was executed at a price of $68.62 per share under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person, and was coded as a sale transaction. After this trade, the officer beneficially owns 70,179 shares of DocuSign common stock, held directly.